Friday, 12 April 2019

Cipla Has Launched Niveoli, India’s First Extra Fine Particle

Cipla has launched Niveoli, India’s first extra-fine particle beclomethasone-formoterol combination hydrofluoroalkane inhaler for adults, targeting drug delivery to the small airways.

Avenue Supermarts shares fell 1.5 percent in morning on April 12 after global brokerage house Morgan Stanley initiated coverage with underweight rating on the stock. 

 Its target price for the stock stood at Rs 1,120 per share, implying 24 percent downside from current levels.

For more information +91- 6232578593 or visit www.moneymarketmanthan.com

No comments:

Post a Comment

Trends On SGX Nifty Indicate A Positive Opening For The Broader Index In India

Trends on SGX Nifty indicate a positive opening for the broader index in India, with a 31.5 points gain or 0.25 percent. The Nifty future...